Cover Image

Hepatoprotective effect of Qushihuayu formula on non-alcoholic steatohepatitis induced by MCD diet in rat

Abstract Background Non-alcoholic steatohepatitis (NASH) is an advanced form of non-alcoholic fatty liver disease (NAFLD) for which there is yet any standard pharmacotherapy. Traditional Chinese medicine formula such as Qushihuayu (QSHY) composing of multiple bioactive compounds has been used to tre...

Full description

Saved in:

Bibliographic Details
Main Authors:	Qingping Lan (Author), Zhitao Ren (Author), Yan Chen (Author), Guozhen Cui (Author), I. Cheong Choi (Author), Carolina Oi Lam Ung (Author), Hon Ho Yu (Author), Simon Ming-Yuen Lee (Author)
Format:	Book
Published:	BMC, 2021-03-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

LUBAC Formation Is Impaired in the Livers of Mice with MCD-Dependent Nonalcoholic Steatohepatitis
by: Yasuka Matsunaga, et al.
Published: (2015)

The Novel Tetra-Specific Drug C-192, Conjugated Using UniStac, Alleviates Non-Alcoholic Steatohepatitis in an MCD Diet-Induced Mouse Model
by: Jihye Kim, et al.
Published: (2023)

2010, odyssée des modèles de classification diagnostique (MCD)
by: Nathalie Loye
Published: (2010)

Systematic analysis of randomised controlled trials of Chinese herb medicine for non-alcoholic steatohepatitis (NASH): implications for future drug development and trial design
by: Xianwen Chen, et al.
Published: (2023)

Profile of Dog Bite Cases attending M.C.D. Dispensary at Alipur, Delhi
by: Khokhar Anita, et al.
Published: (2003)

Relationship Between sCD163 and mCD163 and Their Implication in the Detection and Typing of Leprosy
by: Farag AGA, et al.
Published: (2020)

Si-Wu-Tang alleviates metabolic dysfunction-associated fatty liver disease by inhibiting ACSL4-mediated arachidonic acid metabolism and ferroptosis in MCD diet-fed mice
by: Xiaoyong Xue, et al.
Published: (2024)

Hepatoprotective effect of botanical drug formula on high-fat diet-induced non-alcoholic fatty liver disease by inhibiting lipogenesis and promoting anti-oxidation
by: De-Shan Ning, et al.
Published: (2022)

Choline-deficient High-fat Diet-induced Steatohepatitis in BALB/c Mice
by: Saut Horas Hatoguan Nababan, et al.
Published: (2021)

Overexpression of ORMDL3 confers sexual dimorphism in diet-induced non-alcoholic steatohepatitis
by: Ryan D.R. Brown, et al.
Published: (2024)

A minimal change disease (MCD) related nephrotic syndrome preceding a Hodgkin Lymphoma diagnosis - A case report
by: Pedro Almiro e Castro, et al.
Published: (2022)

Medicinal Formula Huazhi-Rougan Attenuates Non-Alcoholic Steatohepatitis Through Enhancing Fecal Bile Acid Excretion in Mice
by: Chunlin Li, et al.
Published: (2022)

Ouabain inhibits monocyte activation in vitro: prevention of the proinflammatory mCD14+/CD16+ subset appearance and cell-size progression
by: Valente RC, et al.
Published: (2012)

Metformin Alleviates Steatohepatitis in Diet-Induced Obese Mice in a SIRT1-Dependent Way
by: Wan-rong Guo, et al.
Published: (2021)

High-fat diet decreases activity of the oxidative phosphorylation complexes and causes nonalcoholic steatohepatitis in mice
by: Inmaculada García-Ruiz, et al.
Published: (2014)

CD4+RORγt++ and Tregs in a Mouse Model of Diet-Induced Nonalcoholic Steatohepatitis
by: Luisa Vonghia, et al.
Published: (2015)

A clinical experience-based Chinese herbal formula improves ethanol-induced drunken behavior and hepatic steatohepatitis in mice models
by: Han Gao, et al.
Published: (2023)

Hepatoprotective Effect of Tectoridin and Tectorigenin on tert-Butyl Hyperoxide-Induced Liver Injury
by: Hae-Ung Lee, et al.
Published: (2005)

Pharmacological stimulation of p53 with low-dose doxorubicin ameliorates diet-induced nonalcoholic steatosis and steatohepatitis
by: Begoña Porteiro, et al.
Published: (2018)

Application of implementation science framework to develop and adopt regulatory science in different national regulatory authorities
by: Junnan Shi, et al.
Published: (2023)

Steatohepatitis in Children with Obesity
by: Alexander A. Zvyagin, et al.
Published: (2021)

Omalizumab-Associated Steatohepatitis
by: J. Barbosa, et al.
Published: (2023)

Matrine Protects Against MCD-Induced Development of NASH via Upregulating HSP72 and Downregulating mTOR in a Manner Distinctive From Metformin
by: Ali Mahzari, et al.
Published: (2019)

Extracts of Vine Tea Improve Diet-Induced Non-Alcoholic Steatohepatitis Through AMPK-LXRα Signaling
by: Yu-jun Chen, et al.
Published: (2021)

Mitochondrial gene polymorphisms alter hepatic cellular energy metabolism and aggravate diet-induced non-alcoholic steatohepatitis
by: Torsten Schröder, et al.
Published: (2016)

Hepatoprotective Effects of a Ruthenium(II) Schiff Base Complex in Rats with Diet-Induced Prediabetes
by: Lindokuhle Patience Mabuza, et al.
Published: (2019)

Ductular reaction in alcoholic steatohepatitis, nonalcoholic steatohepatitis and hepatitis C virus infection (immunohistochemical study)
by: O. M. Gavrilyuk
Published: (2014)

Oligonucleotide therapies for nonalcoholic steatohepatitis
by: Sixu Li, et al.
Published: (2024)

Fructose and Non-Alcoholic Steatohepatitis
by: Elke Roeb, et al.
Published: (2021)

Obeticholic acid and ferrostatin-1 differentially ameliorate non-alcoholic steatohepatitis in AMLN diet-fed ob/ob mice
by: Shengjie Li, et al.
Published: (2022)

Micronized Palmitoylethanolamide Ameliorates Methionine- and Choline-Deficient Diet-Induced Nonalcoholic Steatohepatitis via Inhibiting Inflammation and Restoring Autophagy
by: Jiaji Hu, et al.
Published: (2021)

Comparison of clinical, biochemical and histological features of alcoholic steatohepatitis and non-alcoholic steatohepatitis in Asian Indian patients
by: Singh Deepak, et al.
Published: (2010)

Hepatoprotective and Antioxidant Potential of Organic and Conventional Grape Juices in Rats Fed a High-Fat Diet
by: Iselde Buchner, et al.
Published: (2014)

Hepatoprotective and Anti-Oxidative Effects of Total Flavonoids From Qu Zhi Qiao (Fruit of Citrus Paradisi cv.Changshanhuyou) on Nonalcoholic Steatohepatitis In Vivo and In Vitro Through Nrf2-ARE Signaling Pathway
by: Zheng Shi, et al.
Published: (2020)

Parents' intention for their children to receive COVID-19 vaccine: Implications for vaccination program in Macao
by: Un I Choi, et al.
Published: (2022)

Chymase inhibitor prevents the development and progression of non-alcoholic steatohepatitis in rats fed a high-fat and high-cholesterol diet
by: Yuta Miyaoka, et al.
Published: (2017)

Is non-alcoholic steatohepatitis caused by alcohol?
by: Hubert E Blum
Published: (2020)

The galectin-3 inhibitor selvigaltin reduces liver inflammation and fibrosis in a high fat diet rabbit model of metabolic-associated steatohepatitis
by: Paolo Comeglio, et al.
Published: (2024)

A systematic review of self-medication practice during the COVID-19 pandemic: implications for pharmacy practice in supporting public health measures
by: Yu Zheng, et al.
Published: (2023)

Hepatoprotective Natural Products
by: Omayma A. Eldahshan
Published: (2017)